Form 4: HealthEquity Director Acquires Shares

HealthEquity, Inc. Director Stuart B. Parker acquired 2,877 shares of common stock through restricted stock units.

Summary

• Stuart B. Parker, a Director at HealthEquity, Inc., acquired 2,877 shares of common stock.
• The acquisition was made through restricted stock units (RSUs) which represent a contingent right to receive one share of common stock.
• These RSUs vest in full on June 25, 2027, or the date of the issuer's next annual stockholder meeting in June 2027, whichever comes first.
• Delivery of vested shares will occur upon a change of control, termination of service, or death of the reporting person.
• Following the transaction, Mr. Parker beneficially owns 25,975 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard equity award transaction for a director rather than a significant new investment or divestment.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition is through RSUs, which are a common form of equity compensation for executives and directors.

Risks

• The RSUs are subject to vesting conditions, meaning the shares are not immediately transferable.
• Delivery of shares is contingent on specific events such as change of control, termination of service, or death.

Future Outlook

The restricted stock units are set to vest on June 25, 2027, or the date of the issuer's next annual stockholder meeting in June 2027, with delivery of shares contingent on specific events.

Industry Context

StockSavvy.ai notes that director acquisitions of stock, particularly through equity awards like RSUs, are common within the health technology and financial services sectors as a means of aligning management and director interests with those of shareholders.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but the transaction itself does not immediately increase the public float.
• Management/Directors: The transaction reflects the standard compensation and equity incentive structure for directors.

Next Steps

• Vesting of restricted stock units on June 25, 2027, or the next annual stockholder meeting in June 2027.
• Delivery of vested shares upon change of control, termination of service, or death.

Key Dates

Keywords

HealthEquity, HQY, Form 4, Insider Trading, Restricted Stock Units, Director, Common Stock, SEC Filing